Ligand validation:3QPB

URA: URACIL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3QPB_URA_L_1255	97%	5%	0.063	0.979	1.91	3.24	3	6	0	0	100%	1
3QPB_URA_B_1255	96%	6%	0.068	0.979	1.9	3.23	3	6	0	0	100%	1
3QPB_URA_A_1255	96%	5%	0.066	0.975	1.91	3.24	3	6	0	0	100%	1
3QPB_URA_D_1255	96%	6%	0.069	0.977	1.9	3.24	3	6	0	0	100%	1
3QPB_URA_K_1255	95%	5%	0.069	0.975	1.91	3.26	3	6	0	0	100%	1
3QPB_URA_N_1255	95%	5%	0.061	0.966	1.9	3.25	3	6	0	0	100%	1
3QPB_URA_I_1255	95%	5%	0.073	0.977	1.9	3.25	3	6	0	0	100%	1
3QPB_URA_E_1255	95%	6%	0.072	0.974	1.91	3.23	3	6	0	0	100%	1
3QPB_URA_J_1255	93%	6%	0.077	0.971	1.9	3.22	3	6	0	0	100%	1
3QPB_URA_F_1255	90%	6%	0.076	0.96	1.91	3.21	3	6	0	0	100%	1
3QPB_URA_Q_1255	90%	6%	0.083	0.967	1.89	3.23	3	6	0	0	100%	1
3QPB_URA_H_1255	90%	5%	0.084	0.966	1.91	3.25	3	6	0	0	100%	1
3QPB_URA_R_1255	90%	6%	0.081	0.962	1.9	3.24	3	6	0	0	100%	1
3QPB_URA_M_1255	88%	6%	0.082	0.958	1.89	3.24	3	6	0	0	100%	1
3QPB_URA_G_1255	87%	6%	0.093	0.965	1.9	3.18	3	6	0	0	100%	1
3QPB_URA_C_1255	86%	5%	0.085	0.952	1.92	3.23	3	6	0	0	100%	1
3QPB_URA_P_1255	82%	6%	0.096	0.951	1.9	3.24	3	6	0	0	100%	1
3QPB_URA_O_1255	80%	5%	0.093	0.94	1.91	3.24	3	6	0	0	100%	1
4WPL_URA_A_301	100%	37%	0.052	0.995	1.11	1.36	1	1	0	0	100%	1
5MIW_URA_B_303	100%	3%	0.054	0.996	3.17	2.78	7	3	0	0	100%	1
5LHV_URA_F_303	98%	1%	0.063	0.988	4.64	4.17	8	5	0	0	100%	0.69
2RJ3_URA_A_8001	98%	7%	0.062	0.985	1.6	3.18	2	6	0	0	100%	1
4OEH_URA_E_301	97%	9%	0.063	0.981	1.61	2.88	1	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.